Schedule 13G ownership disclosure

TITAN PHARMACEUTICALS INC D COM

Security class unavailable · CUSIP: 888314507

Event date: 2020-09-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,720,000
Percent of class
8.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000113
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Sep 24, 2020
Reporting period
Sep 24, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub